Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2022-05-24 00:00:00 ET · period of report 2022-05-23 · accession 0001628280-22-015279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-24 | 2022-05-23 | LFCR | Bolles Albert D. | CEO | M - OptEx | $9.45 | +55.0K | 100.2K | +122% | +$519.7K |
| D | 2022-05-24 | 2022-05-23 | LFCR | Bolles Albert D. | CEO | F - Tax | $9.45 | -27.3K | 72.9K | -27% | -$257.7K |
| D | 2022-05-24 | 2022-05-23 | LFCR | Bolles Albert D. | CEO | M - OptEx | $9.45 | -55.0K | 0 | -100% | -$519.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-23 | M | A | 55,000 | $9.45 | 100,152 | D | — | — | (F1) The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| 2 | Common | Common Stock | 2022-05-23 | F | D | 27,269 | $9.45 | 72,883 | D | — | — | (F1) The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| 3 | Derivative | Common Stock | 2022-05-23 | M | D | 55,000 | $9.45 | 0 | D | — · 2022-05-23 to 2022-05-23 | 55,000 Common Stock | (F2) The restricted stock units were granted on May 23, 2019. (F1) The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. (F3) The restricted stock units vested on May 23, 2022. |